Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
"A multicenter, multinational, prospective, interventional,single-arm, Phase IV study evaluating the clinicalefficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insulin"	SANOFI	Ongoing	TOUJEO	4	LPS15396	Sultan bin Abdulaziz Humanitarian city (Riyadh)
A prospective Randomized study of General Anesthesia versus Anesthetist Administered sedation for ERCP	King Abdullah Medical City (Makkah)	Ongoing	FENTANYL/ CISATRACURIUM/ SEVOFLURANE	4	18-492	King Abdullah Medical City (Makkah)
"A multi-centre prospective non-interventional studyinvestigating the clinical effectiveness of Ryzodeg® (InsulinDegludec/Insulin Aspart) in patients with type 2 diabetesmellitus in a real-world setting"	Novo Nordisk	Ongoing	Ryzodeg Flex Touch	4	NN54014525	King Abdulaziz University Hospital (Jeddah), Ghassan Najeeb Pharaon hospital (Jeddah), Saudi German Hospital (Jeddah), Umm Al-Qura University (Makkah), Dallah Hospital (Riyadh), Riyadh Care Hospital (Riyadh), Specialized Medical Center (Riyadh), King Abdulaziz Medical City NG (Riyadh)
CRAD001H2406- A long-term non-interventional observational study in Living Donor Liver Transplant Recipients (LDLTRs) with primary hepatocellular carcinoma (HCC) treated with Certican® / Zortress® (everolimus; EVR) plus reduced tacrolimus (rTAC) versus standard tacrolimus (sTAC) control	Novartis	Ongoing	• everolimus • reduced tacrolimus	4	CRAD001H24	King Faisal Specialist Hospital and Research Center (Riyadh)
A prospective, multicenter, observational study to evaluate patients’ quality oflife in routine clinical practice in patients with relapsing-remitting multiplesclerosis (RRMS) treated with LEMTRADA®	Sanofi	Ongoing	alemtuzumab	4	OBS15590	Al-Noor Specialist Hospital (Makkah), King Khalid University Hospital (Riyadh), King Saud Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis	Bristol-Myers Squibb	Ongoing	Abatacept	4	IM101240	King Abdulaziz Medical City NG (Riyadh)
An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform®	Mundipharma	Ongoing	Flutiform	4	FLT18-KSA	King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh)
A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with type 2 diabetes mellitus, treated with insulin glargine 300 U/mL (insulin glargine U300) before, during and after the period of Ramadan / ORION study	Sanofi	Ongoing	Toujeo	4	OBS16040	King Abdulaziz University Hospital (Jeddah), Alzafer Hospital (Najran), University District Hospital (Jeddah), Saudi German Hospital (Jeddah)
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatitis 2ry Caused by Infection With Fungi	Jamjoom Pharmaceuticals	Ongoing	Betazole	4	BETA001	King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)
An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria	Jamjoom Pharmaceuticals	Ongoing	Elica-M	4	ELICA-M001	King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)